Conference abstract · 28 Sep 2018
Conference abstractPublished 26 Oct 2015
Compliance and traceability (CAT) using regulatory intelligence (RI)
Wipro Technologies, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Given the increased scrutiny of the agencies and not forgetting the un-announced inspections in Europe, it is imperative to have a good handle on compliance as all compliance risks are business risks. Hence, Compliance and Traceability for the life sciences industry is the need of the hour, which will create a baseline for what are all the regulations and standards that a business needs to be complying to globally and also manage the new and changing regulations in an ongoing basis. To create the base line the source should be a dependable source of the global regulations and standards (called Regulatory Intelligence). Example of one RI source is Tarius (Denmark based), which will provide what regulations and standards to be complied to globally. Using this source, one can create a baseline and monitor for all the changing and new regulations (and standards). This will enable businesses to know and track what needs to be complied to and monitor it. This is known businesses can also do what is needed to comply and provide traceability to what is done to provide compliance evidence. This entire set up can significantly enhance compliance which will result in having a great control on price of non-compliance.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Jun 2026
Regulatory Compliance: Ensuring Ethical Standards and Responsible Professional Practices
Article · 31 Dec 2025
Maintaining Pharmaceutical Integrity Through Regulatory Analytical Compliance Systems
Commentary · 29 Nov 2025
Ensuring Patient Safety Through Drug Regulatory Compliance
Short communication · 30 Apr 2025
Clinical Trial Design in Drug Development: Best Practices for Successful Trials and Regulatory Compliance
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Rama K Pidaparti”

